125 related articles for article (PubMed ID: 10591510)
1. L- and D- methionine provide equivalent long term protection against CDDP-induced ototoxicity in vivo, with partial in vitro and in vivo retention of antineoplastic activity.
Reser D; Rho M; Dewan D; Herbst L; Li G; Stupak H; Zur K; Romaine J; Frenz D; Goldbloom L; Kopke R; Arezzo J; Van De Water T
Neurotoxicology; 1999 Oct; 20(5):731-48. PubMed ID: 10591510
[TBL] [Abstract][Full Text] [Related]
2. Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy.
Li G; Frenz DA; Brahmblatt S; Feghali JG; Ruben RJ; Berggren D; Arezzo J; Van De Water TR
Neurotoxicology; 2001 Apr; 22(2):163-76. PubMed ID: 11405249
[TBL] [Abstract][Full Text] [Related]
3. Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells.
Kopke RD; Liu W; Gabaizadeh R; Jacono A; Feghali J; Spray D; Garcia P; Steinman H; Malgrange B; Ruben RJ; Rybak L; Van de Water TR
Am J Otol; 1997 Sep; 18(5):559-71. PubMed ID: 9303151
[TBL] [Abstract][Full Text] [Related]
4. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
Dickey DT; Wu YJ; Muldoon LL; Neuwelt EA
J Pharmacol Exp Ther; 2005 Sep; 314(3):1052-8. PubMed ID: 15951398
[TBL] [Abstract][Full Text] [Related]
5. D-methionine provides excellent protection from cisplatin ototoxicity in the rat.
Campbell KC; Rybak LP; Meech RP; Hughes L
Hear Res; 1996 Dec; 102(1-2):90-8. PubMed ID: 8951454
[TBL] [Abstract][Full Text] [Related]
6. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
Huang X; Whitworth CA; Rybak LP
Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of D-methionine as a novel oral radiation protector for prevention of mucositis.
Vuyyuri SB; Hamstra DA; Khanna D; Hamilton CA; Markwart SM; Campbell KC; Sunkara P; Ross BD; Rehemtulla A
Clin Cancer Res; 2008 Apr; 14(7):2161-70. PubMed ID: 18381958
[TBL] [Abstract][Full Text] [Related]
8. Prevention of noise- and drug-induced hearing loss with D-methionine.
Campbell KC; Meech RP; Klemens JJ; Gerberi MT; Dyrstad SS; Larsen DL; Mitchell DL; El-Azizi M; Verhulst SJ; Hughes LF
Hear Res; 2007 Apr; 226(1-2):92-103. PubMed ID: 17224251
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the effect of acetyl L-carnitine on experimental cisplatin ototoxicity and neurotoxicity.
Gunes D; Kirkim G; Kolatan E; Guneri EA; Ozogul C; Altun Z; Serbetcioglu B; Yilmaz O; Aktas S; Mutafoglu K; Tufekci O; Erbayraktar Z; Olgun N
Chemotherapy; 2011; 57(3):186-94. PubMed ID: 21525749
[TBL] [Abstract][Full Text] [Related]
10. Effect of noise conditioning on cisplatin-induced ototoxicity: a pilot study.
Theneshkumar S; Lorito G; Giordano P; Petruccelli J; Martini A; Hatzopoulos S
Med Sci Monit; 2009 Jul; 15(7):BR173-7. PubMed ID: 19564816
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
12. Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model.
Thomas Dickey D; Muldoon LL; Kraemer DF; Neuwelt EA
Hear Res; 2004 Jul; 193(1-2):25-30. PubMed ID: 15219317
[TBL] [Abstract][Full Text] [Related]
13. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
[TBL] [Abstract][Full Text] [Related]
14. L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity.
Feghali JG; Liu W; Van De Water TR
Laryngoscope; 2001 Jul; 111(7):1147-55. PubMed ID: 11568534
[TBL] [Abstract][Full Text] [Related]
15. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin cytotoxicity in organ of Corti-derived immortalized cells.
Previati M; Lanzoni I; Astolfi L; Fagioli F; Vecchiati G; Pagnoni A; Martini A; Capitani S
J Cell Biochem; 2007 Aug; 101(5):1185-97. PubMed ID: 17243113
[TBL] [Abstract][Full Text] [Related]
17. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
[TBL] [Abstract][Full Text] [Related]
18. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.
Wang J; Ladrech S; Pujol R; Brabet P; Van De Water TR; Puel JL
Cancer Res; 2004 Dec; 64(24):9217-24. PubMed ID: 15604295
[TBL] [Abstract][Full Text] [Related]
19. d-Methionine protects against cisplatin-induced neurotoxicity in cortical networks.
Gopal KV; Wu C; Shrestha B; Campbell KC; Moore EJ; Gross GW
Neurotoxicol Teratol; 2012; 34(5):495-504. PubMed ID: 22732230
[TBL] [Abstract][Full Text] [Related]
20. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
